- All Journals
- Al-Qadisiyah University
- Basrah University
- Kirkuk University
- Mosul University
- The Iraqi Borad for Medical Specialization
- University of Anbar
- University of Technology
- Al Mustafa University
- Al-Zahraa University for Women
- Alnoor University
- Kunooz University
- Misan University
- Ninevah University
- Tikrit University
- University of Al-Hamdaniya
- University of Kerbala
Neutrophil Extracellular Traps: A New Tool that Reflects the Progression of Tumor Status in Acute Lymphoblastic Leukemia Patients | ||
| Rafidain Journal of Science | ||
| Articles in Press, Accepted Manuscript, Available Online from 02 August 2025 | ||
| Document Type: Research Paper | ||
| DOI: 10.33899/rjs.2025.159218.1450 | ||
| Authors | ||
| sura mahmoud Al-Taee* 1; Rojan G.M. AL-Allaff2 | ||
| 1علوم الحياة/كلية العلوم /جامعة الموصل /الموصل /العراق | ||
| 2University of Mosul / College of Sciences / Biology department / Mosul / Iraq | ||
| Abstract | ||
| Acute lymphoblastic leukemia (ALL) is a malignant proliferation of immature lymphocytes known as lymphoblast that causes them to build up in several organs, including the bone marrow and blood. Cancer cells use Neutrophil Extracellular Traps (NETs) as a key component of their immune evasion strategies. The goal of the study is to estimate NETs levels in pediatric patients with ALL, as it is a promising immunological marker for tumor diagnosis and disease progression. A total of 80 children aged 1 to 14 years diagnosed with acute lymphoblastic leukemia were selected, alongside 40 healthy children served as the control group. The samples from ALL patients were split into three groups based on the duration of the disease. Serum levels of NETs were ascertained using the ELISA technique. The results showed a significant increase in the levels of NETs among ALL patients (Mean ±SD 1125.400 ± 739.165 ng/ml) compared to the control group (Mean±SD 622.363 ± 127.983 ng/ml) with P≤0.05. Additionally, no significant differences in NETs were observed among the three disease groups, as the p-value associated with Duncan test was 0.33. However, both the Less than 1 year and more than 2 years showed a significant increase in NETs levels compared with the control group, according to Duncan’s test. The findings suggest that NETs were able to reverse the progression of the tumor during the treatment stages. | ||
| Keywords | ||
| Acute Lymphoblastic Leukemia; Biomarker; Cancer; Diagnosis; NETs | ||
|
Statistics Article View: 117 |
||